Thomas M. Gorrie is presently a senior global business advisor to numerous organizations and has extensive worldwide healthcare experience.

He retired in 2008 from Johnson & Johnson after 35 years. At J&J, he held senior positions in research and development, marketing and sales, business development, strategic planning, international, venture capital, health policy, and general management, including the position of Company Group Chairman responsible for a large global medical device business. He most recently was a Corporate Officer and Corporate Vice President of Government Affairs and Policy worldwide.

Dr. Gorrie received his Bachelor of Arts degree from Rutgers University and his masters and doctoral degrees in chemistry from Princeton University. He completed post-doctoral studies at the Swiss Federal Institute of Technology in Zurich.

He currently serves as a Trustee for Duke Kunshan University in Kunshan, PRC, is on the Advisory Board of Duke Global Health Institute, is on the Advisory Board of the Duke School of Medicine, is a Distinguished Executive in Residence and Adjunct Professor at the Rutgers Business School, is a Senior Advisor to the China Association of Enterprises with Foreign Investments in China and is chair of the Board of Trustees of the Vail Health System in Colorado. Over the years, he has served on numerous boards including the Robert Wood Johnson University Hospital Board, where he was chair; the Duke University Board, the Duke University Health System Board, where he was chair; Duke-NUS Medical School Board in Singapore; Robert Wood Johnson Foundation, Non-Executive Director of the Board of the British Standard Institute in the United Kingdom and Trustee of the Hun School of Princeton. He also served as a Senior Advisor to the United States Chamber of Commerce.

Dr. Gorrie has written many peer-reviewed scientific articles, holds two patents, has made numerous presentations on a broad variety of subjects globally and co-edited the book “Ethics and the Pharmaceutical Industry”.